Ocugen (OCGN) Total Current Liabilities (2014 - 2026)
Ocugen (OCGN) posted Total Current Liabilities of $20.7 million for Q1 2026, down 10.13% on a QoQ basis from $23.0 million in Q4 2025, and up 22.63% year-over-year from $16.9 million in Q1 2025.
Ocugen (OCGN) Total Current Liabilities (2014 - 2026) Analysis & Trends
Ocugen's Total Current Liabilities history runs 13 years deep, the most recent figure standing at $20.7 million for Q1 2026.
- Quarterly Total Current Liabilities rose 22.63% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.7 million (up 22.63% YoY) and the FY2025 annual result came in at $23.0 million, up 6.74% from the prior year.
- Total Current Liabilities was $20.7 million for Q1 2026 at Ocugen, down from $23.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $28.5 million in Q4 2022 and bottomed at $13.3 million in Q1 2022.
- A 5-year average of $20.2 million and a median of $19.7 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 307.59% — and 2023, when it sank 40.1%.
- Ocugen's Total Current Liabilities stood at $28.5 million in 2022, then sank by 40.1% to $17.1 million in 2023, then climbed by 26.33% to $21.6 million in 2024, then rose by 6.74% to $23.0 million in 2025, then retreated by 10.13% to $20.7 million in 2026.
- Business Quant data shows OCGN's Total Current Liabilities at $20.7 million in Q1 2026, $23.0 million in Q4 2025, and $20.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | 20.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.71 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 20.36 Mn |
| Jun 30, 2025 | 17.99 Mn |
| Mar 31, 2025 | 16.89 Mn |
| Dec 31, 2024 | 21.59 Mn |
| Sep 30, 2024 | 15.76 Mn |
| Jun 30, 2024 | 17.97 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 19.73 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 26.58 Mn |
| Dec 31, 2022 | 28.53 Mn |
| Sep 30, 2022 | 24.52 Mn |
| Jun 30, 2022 | 17.96 Mn |
| Mar 31, 2022 | 13.30 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | 4.84 Mn |